Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06330844

Race-Based Stress and Cognitive Training for MCI

This a two phase project that aims to pilot a new adaptation (Phase 1) of Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT; an originally VA-based cognitive rehabilitation manualized intervention for older adults with MCI, with a focus on the impact of stress on cognitive functioning; that integrates components from the Race Based Stress and Empowerment (RBSE) group for an increased focus on race-based stress and discrimination for racial minority older adults (i.e., RBSEF-CCT-MCI). In a pilot open trial, 75-150 participants will receive group-based intervention for 8 weeks, with 8-10 participants per group.

Following the pilot study, the investigators will complete a randomized controlled trial (RCT) (Phase 2) to compare the efficacy of the RBSEF-CCT-MCI with the ME-CCT. In the RCT, 75-150 participants will be randomized into either 1) The active control group, who will complete the original, ME-CCT training program, or 2) The experimental group, who will complete the newly developed RBSE-CCT-MCI. Both research groups will complete the interventions for 8 weeks, with 8-10 participants per group.

Hypothesis: Participation in this newly developed/updated intervention (i.e., RBSEF-CCT-MCI) will result in improvements in both (a) subjective and (b) objective cognitive functioning, and (c) self-reported mental health symptoms.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Mild Cognitive Impairment Cognition Disorders Cognitive Dysfunction Mental Disorders Neurocognitive Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rosalind Franklin University of Medicine and Science

Chicago, Illinois, 60064, United States

Location status: Recruiting

Location contact

Rachael Ellison, PhD

CONTACT

312-940-1718

Rachael Ellison, PhD

PRINCIPAL_INVESTIGATOR

About this study

African American (AA) individuals are at higher risk for non-normative cognitive decline, particularly due to increased rates of cardiovascular and cerebrovascular risk factors. These types of risk factors (e.g., hypertension, diabetes mellitus, obesity, hyperlipidemia, etc.) are independently associated with brain imaging changes, even before potential clinical manifestation of cardiovascular or cerebrovascular disease.

When compared to the general aging population, AA adults experience disproportionately higher rates of hypertension as well as both an earlier age of onset and higher concomitant morbidity and mortality from hypertension when compared to any other racial/ethnic group in the US. AA individuals experience greater exposure to specific chronic stressors, such as discrimination and low socioeconomic status, as well as report higher overall levels of stress compared to white individuals. However, racial disparities in hypertension rates persist even after controlling for socioeconomic status. Researchers have failed to demonstrate any risk factors that are biologically unique to AA patients. These findings have led researchers to consider other psychosocial and environmental factors that may explain the observed hypertension disparities, namely, racial discrimination and racial segregation.

AA older adults are not only at higher risk for non-normative cognitive decline due to both semi-direct (i.e., increased risk of cardiovascular/cerebrovascular risk factors, such as HTN), but other factors such as race-related stress may not only exacerbate these risk factors, but also interfere day-to-day with optimal cognitive performance due to overall increased stress and diversion of cognitive resources. Therefore, for AA older adults, there is an increased need not only for interventions that help to compensate for cognitive decline and increase daily functioning, but also an increased need for an intervention to reduce the effects of race-related stressors. The proposed Race-Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI) as proposed in this pilot, is one such intervention that would accomplish those aims and has the potential for a significant impact on patient care for AA older adults who could benefit from additional tools and strategies to improve cognitive functioning and increase day-to-day independent functioning.

Of note, original authors of both protocols have granted consent for modifications of their interventions, and the investigators already have a draft of the new protocol.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The study will be conducted in-person, so they must be able to travel to Rosalind Franklin University.
  • The study will initially be limited to participants who self-identify as Black/African American, or who self-identify with other racial/ethnic groups in addition to self-identifying as Black/African-American; however, may be expanded to include participants that identify as Hispanic/Latine.

Exclusion criteria

  • Participants are ineligible to participate in this study if they are not at least 65 years of age and are not experiencing at least mild cognitive impairment or self-reported cognitive difficulties.
  • Participants will also be excluded if they have a diagnosis of dementia (i.e., major neurocognitive disorder), intellectual disability, mild head injury (i.e., concussion) within the last six months, and/or a history of moderate to severe traumatic brain injury.
  • Diagnosis of dementia may be from self-report or other medical records, or for participants to fail screening cognitive assessments (i.e., the RBANS) that would suggest they may be at the level of dementia (i.e., major neurocognitive disorder) as ultimately determined by study PI with objective scores less then 2 standard deviations below the mean on the RBANS.

Treatment and study plan

Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment (RBSEF-CCT-MCI)

Behavioral

RBSEF-CCT-MCI differs from ME-CCT in that this intervention integrates psychoeducation and strategies for processing and coping with race/ethnicity-related stressors, as part of the larger conversation in ME-CCT regarding stress, and how stress interferes with attention, learning, and subsequently one's subjective sense of memory.

Motivationally Enhanced Compensatory Cognitive Training for Mild Cognitive Impairment (ME-CCT)

Behavioral

ME-CCT focuses on:

  • Cognitive training, psychotherapeutic, and lifestyle techniques.
  • Incorporates CCT techniques designed to help patients manage problems with memory, attention, and executive functions (i.e., organization, planning, decision-making, and problem-solving).
  • Includes mindfulness-based stress reduction practice which has been shown to improve cognitive and neuropsychiatric function in various populations.

Primary outcomes

  1. Verbal learning and memory

    Time frame: up to eight weeks

    Assessed by the California Verbal Learning Test- Second Edition (CVLT-II)

  2. Basic auditory attention and working memory

    Time frame: up to eight weeks

    Assessed by the Digit Span subtest of the Wechsler Adult Intelligence Scale (WAIS-IV)

  3. Psychomotor processing speed

    Time frame: up to eight weeks

    Assessed by the Coding and Symbol search subtests of the WAIS-IV

  4. Psychomotor processing speed; executive functioning

    Time frame: up to eight weeks

    As assessed by the Stroop Test

  5. Self-report of prospective and retrospective memory

    Time frame: up to eight weeks

    The Prospective and Retrospective Memory Questionnaire (PRMQ). The PRMQ developed to provide a self-report measure of prospective and retrospective memory slips in everyday life. It consists of sixteen items, eight asking about prospective memory failures, and eight concerning retrospective failures.

  6. Self-report of cognitive concerns

    Time frame: up to eight weeks

    Neuro-QOL (neuro-quality of life); applied cognition: general concerns & executive functioning (EF) subscales

  7. The Patient Health Questionnaire-9

    Time frame: up to eight weeks

    (i.e., PHQ-9; assessing self-report symptoms of depression)

  8. Self-report symptoms of anxiety

    Time frame: up to eight weeks

    As assessed by the Generalized Anxiety Disorder-7 questionnaire (i.e., GAD-7)

  9. Self-reported daily functioning

    Time frame: up to eight weeks

    As assessed by The World Health Organization Disability Assessment Schedule 2.0 (i.e., WHODAS 2.0)

  10. The Racial Microaggressions Scale

    Time frame: up to eight weeks

    Assessing the occurrence and distress elicited by racial indignities, slights, mistreatment, or offenses that people of color may face on a recurrent or consistent basis.

  11. The Trauma Symptoms of Discrimination Scale

    Time frame: up to eight weeks

    Self-report measure assessing the traumatizing impact of discrimination broadly by measuring anxiety-related symptoms of trauma due to discriminatory experiences

Study contacts

Contact information is provided by the study sponsor or research team.

Rachael L Ellison, PhD

CONTACT

[email protected]

(847) 578-3000

Sponsors and collaborators

Lead sponsor

Rosalind Franklin University of Medicine and Science

Other

Registry information

Official study title

Race Based Stress and Empowerment Focused Compensatory Cognitive Training for Mild Cognitive Impairment

Important dates

Study start
2025
Primary completion
2027
Study completion
2028
First posted
Mar 26, 2024
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.